Image source: Shutterstock
Highlights
- ESCT to conduct a tender offer for up to 42.5% of shares, subject to approval
- Saba commits to tender over 115 million shares and observe standstill covenants
- Tender offer includes both cash and in specie options for eligible shareholders
Saba Capital Management, L.P. ("Saba") has entered into a standstill agreement with The European Smaller Companies Trust PLC (LSE: ESCT), following a series of negotiations with the Trust’s Board. The agreement outlines a framework intended to offer liquidity to shareholders and outlines mutual commitments between the parties through 2028.
A central feature of the agreement is a proposed tender offer, subject to shareholder approval, for up to 42.5% of ESCT’s ordinary shares in issue. Shareholders listed on the register at 6:00 p.m. BST on 16 April 2025 will be eligible to participate. The tender offer will provide shareholders with an option to receive either cash or in specie consideration in exchange for their shares.
Saba, one of the Trust’s largest shareholders, has agreed to tender 115,386,122 of its shares in the offer. Additionally, it has committed to comply with a series of standstill provisions that will remain in effect until the conclusion of ESCT’s annual general meeting in 2028, unless certain conditions trigger an earlier termination under the agreement’s terms.
The announcement follows Saba’s broader campaign to influence corporate actions across several UK-listed investment trusts. According to Saba, ESCT is now the fifth trust to make changes following its engagement efforts. The firm has advocated for shareholder-focused reforms including enhanced liquidity and governance.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
References to ‘Kalkine’, ‘we’, ‘our’ and ‘us’ refer to Kalkine Limited.
This website is a service of Kalkine Limited. Kalkine Limited is a private limited company, incorporated in England and Wales with registration number 07903332. Kalkine Limited is authorised and regulated by the Financial Conduct Authority under reference number 579414.
The article has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. No advice or information, whether oral or written, obtained by you from Kalkine or through or from the service shall create any warranty not expressly stated. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation.
Kalkine does not offer financial advice based upon your personal financial situation or goals, and we shall NOT be held liable for any investment or trading losses you may incur by using the opinions expressed in our publications, market updates, news alerts and corporate profiles. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation. Kalkine’s non-personalised advice does not in any way endorse or recommend individuals, investment products or services for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional authorised financial planner and adviser. You should be aware that the value of any investment and the income from it can go down as well as up and you may not get back the amount invested.
Kalkine Media Limited, an affiliate of Kalkine Limited, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.